Singh, H., Manning, M., McElwee-Malloy, M., & Habif, S. (2020). SAT-LB113 Psychosocial Benefits of Using Basal-IQ® Predictive Low Glucose Suspend Technology in a Real-World Setting: Results From Pediatric Patients With Type 1 Diabetes. J Endocr Soc.
Chicago-tyylinen lähdeviittausSingh, Harsimran, Michelle Manning, Molly McElwee-Malloy, ja Steph Habif. "SAT-LB113 Psychosocial Benefits of Using Basal-IQ® Predictive Low Glucose Suspend Technology in a Real-World Setting: Results From Pediatric Patients With Type 1 Diabetes." J Endocr Soc 2020.
MLA-viiteSingh, Harsimran, Michelle Manning, Molly McElwee-Malloy, ja Steph Habif. "SAT-LB113 Psychosocial Benefits of Using Basal-IQ® Predictive Low Glucose Suspend Technology in a Real-World Setting: Results From Pediatric Patients With Type 1 Diabetes." J Endocr Soc 2020.